Loading...
Fisher & Paykel Healthcare Corporation Limited
FSPKF•PNK
Healthcare
Medical - Instruments & Supplies
$20.01
$0.00(0.00%)
Fisher & Paykel Healthcare Corporation Limited (FSPKF) Financial Performance & Income Statement Overview
Review Fisher & Paykel Healthcare Corporation Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
10.67%
↑ 10.67%
Operating Income Growth
-23.99%
↓ 23.99%
Net Income Growth
-47.02%
↓ 47.02%
Operating Cash Flow Growth
80.35%
↑ 80.35%
Operating Margin
-6.85%
↓ 6.85%
Gross Margin
50.14%
↑ 50.14%
Net Profit Margin
23.77%
↑ 23.77%
ROE
27.77%
↑ 27.77%
ROIC
-7.46%
↓ 7.46%
Fisher & Paykel Healthcare Corporation Limited (FSPKF) Income Statement & Financial Overview
Review Fisher & Paykel Healthcare Corporation Limited's (FSPKF) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $951.20M | $939.10M | $815.80M | $894.10M |
| Cost of Revenue | $362.50M | $380.80M | $317.60M | $365.30M |
| Gross Profit | $588.70M | $558.30M | $498.20M | $528.80M |
| Gross Profit Ratio | $0.62 | $0.59 | $0.61 | $0.59 |
| R&D Expenses | $110.10M | $101.30M | $96.90M | $90.10M |
| SG&A Expenses | $260.50M | $256.20M | $236.60M | $229.60M |
| Operating Expenses | $370.60M | $357.50M | $333.50M | $319.70M |
| Total Costs & Expenses | $733.10M | $738.30M | $651.10M | $685.00M |
| Interest Income | $0.00 | $3.80M | $1.40M | $1.10M |
| Interest Expense | $0.00 | $19.00M | $8.70M | $5.50M |
| Depreciation & Amortization | $57.60M | $45.60M | $54.40M | $48.50M |
| EBITDA | $275.70M | $246.40M | $203.70M | $267.70M |
| EBITDA Ratio | $0.29 | $0.26 | $0.25 | $0.29 |
| Operating Income | $218.10M | $200.80M | $164.70M | $209.10M |
| Operating Income Ratio | $0.23 | $0.21 | $0.20 | $0.23 |
| Other Income/Expenses (Net) | -$11.70M | -$105.70M | -$24.10M | $4.60M |
| Income Before Tax | $206.40M | $95.10M | $140.60M | $213.70M |
| Income Before Tax Ratio | $0.22 | $0.10 | $0.17 | $0.24 |
| Income Tax Expense | $53.20M | $69.80M | $33.30M | $59.30M |
| Net Income | $153.20M | $25.30M | $107.30M | $154.40M |
| Net Income Ratio | $0.16 | $0.03 | $0.13 | $0.17 |
| EPS | $0.26 | $0.04 | $0.18 | $0.27 |
| Diluted EPS | $0.26 | $0.04 | $0.18 | $0.27 |
| Weighted Avg Shares Outstanding | $589.23M | $596.77M | $580.58M | $578.54M |
| Weighted Avg Shares Outstanding (Diluted) | $589.39M | $593.22M | $584.54M | $582.33M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan